ArticleGut and liver2021

Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis.

Yong Il Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.